Advanced in Neurosarcoidosis

Dr. Elizabeth R. Volkmann

Rheumatology
200 Ucla Medical Plaza, University Of California Los Angeles David Geffen Schoo, 
Los Angeles, CA 
14 Years of Experience
Advanced in Neurosarcoidosis
200 Ucla Medical Plaza, University Of California Los Angeles David Geffen Schoo, 
Los Angeles, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Elizabeth Volkmann is a Rheumatologist in Los Angeles, California. Dr. Volkmann has been practicing medicine for over 14 years and is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. Her top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Scleroma, and Sarcoidosis.

Her clinical research consists of co-authoring 143 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in CA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

200 Ucla Medical Plaza, University Of California Los Angeles David Geffen Schoo, Los Angeles, CA 90095

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis
A Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 06, 2025
Intervention Type: Drug
Study Drug: HZN-825
Study Phase: Phase 2
A Phase 1 Open-Label Study to Determine the Safety and Tolerability of AVID200: A Transforming Growth Factor β (TGFβ) Inhibitor, in Patients With Diffuse Cutaneous Systemic Sclerosis
A Phase 1 Open-Label Study to Determine the Safety and Tolerability of AVID200: A Transforming Growth Factor β (TGFβ) Inhibitor, in Patients With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Completed
Publish Date: November 19, 2024
Intervention Type: Drug
Study Drug: AVID200 TGFBeta Inhibitor
Study Phase: Phase 1
A Phase 2, Randomized, Placebo-controlled, Double-blind, Open-label Extension Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil (KD025) in Subjects With Diffuse Cutaneous Systemic Sclerosis
A Phase 2, Randomized, Placebo-controlled, Double-blind, Open-label Extension Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil (KD025) in Subjects With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: August 30, 2023
Intervention Type: Drug
Study Drug: Belumosudil (KD025)
Study Phase: Phase 2
A Phase 2, Open-label Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
A Phase 2, Open-label Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Enrollment Status: Terminated
Publish Date: June 05, 2023
Intervention Type: Drug
Study Drug: Belumosudil
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Enrollment Status: Completed
Publish Date: August 16, 2022
Intervention Type: Drug
Study Drug: Lenabasum
Study Phase: Phase 3
View 4 Less Clinical Trials

143 Total Publications

Type III and type VI collagen neoepitopes are associated with disease severity in systemic sclerosis.
Type III and type VI collagen neoepitopes are associated with disease severity in systemic sclerosis.
Journal: The Journal of rheumatology
Published: November 15, 2025
Similar Doctors
Advanced in Neurosarcoidosis
Dr. Purnell A. Kirkland
Rheumatology
Advanced in Neurosarcoidosis
Dr. Purnell A. Kirkland
Rheumatology
575 E Hardy St, Suite 320, 
Inglewood, CA 
 (9.8 miles away)
310-672-8921
Languages Spoken:
English
See accepted insurances

Purnell Kirkland is a Rheumatologist in Inglewood, California. Dr. Kirkland is rated as a Distinguished provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Bursitis, Vasculitis, Tenosynovitis, and Rheumatoid Vasculitis.

Advanced in Neurosarcoidosis
Dr. Sheetal R. Desai
Rheumatology
Advanced in Neurosarcoidosis
Dr. Sheetal R. Desai
Rheumatology

Uc Regents

101 The City Dr S, 
Orange, CA 
 (37.2 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sheetal Desai is a Rheumatologist in Orange, California. Dr. Desai is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. Her top areas of expertise are Rheumatoid Arthritis (RA), Lupus Nephritis, Sarcoidosis, and Neurosarcoidosis.

Experienced in Neurosarcoidosis
Dr. Alan H. Gorn
Rheumatology
Experienced in Neurosarcoidosis
Dr. Alan H. Gorn
Rheumatology

The Regents Of The University Of California

200 Medical Plaza, 
Los Angeles, CA 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Alan Gorn is a Rheumatologist in Los Angeles, California. Dr. Gorn is rated as a Distinguished provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Adult Still's Disease, Dermatomyositis, Rheumatoid Arthritis (RA), and Undifferentiated Connective Tissue Disease (UCTD).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Volkmann's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 15 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile